| 发明名称 |
Combination Therapy For The Treatment Of Schizophrenia |
| 摘要 |
The present invention relates to a combination of a NK3 receptor antagonist with a 5HT2A receptor antagonist and/or a D2 receptor antagonist, and the use of the combination in treating schizophrenia and associated conditions.
|
| 申请公布号 |
US2007203119(A1) |
申请公布日期 |
2007.08.30 |
| 申请号 |
US20050659672 |
申请日期 |
2005.08.01 |
| 申请人 |
DANJOU PHILIPPE;HUTSON PETER H |
发明人 |
DANJOU PHILIPPE;HUTSON PETER H. |
| 分类号 |
A61K31/55;A61K31/00;A61K31/47;A61K31/496;A61K31/519;A61K31/551;A61K45/06 |
主分类号 |
A61K31/55 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
